Registered number
12366541
GKS MURTHY MEDICAL LIMITED
Filleted Accounts
30 November 2025
GKS MURTHY MEDICAL LIMITED
Registered number: 12366541
Balance Sheet
as at 30 November 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 3 97 539
Current assets
Investments held as current assets 4 85,000 -
Cash at bank and in hand 186,248 210,750
271,248 210,750
Creditors: amounts falling due within one year 5 (56,994) (54,113)
Net current assets 214,254 156,637
Net assets 214,351 157,176
Capital and reserves
Called up share capital 100 100
Profit and loss account 214,251 157,076
Shareholders' funds 214,351 157,176
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr Shivalinga Gulyam Kuruba
Director
Approved by the board on 15 July 2026
GKS MURTHY MEDICAL LIMITED
Notes to the Accounts
for the year ended 30 November 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
FA - Plant and machinery 33.33% S.L
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 2 2
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 December 2024 2,377
At 30 November 2025 2,377
Depreciation
At 1 December 2024 1,838
Charge for the year 442
At 30 November 2025 2,280
Net book value
At 30 November 2025 97
At 30 November 2024 539
4 Investments held as current assets 2025 2024
£ £
Fair value
Unlisted investments 85,000 -
5 Creditors: amounts falling due within one year 2025 2024
£ £
Director loan account 27,500 -
Taxation and social security costs 17,494 17,327
Other creditors 12,000 36,786
56,994 54,113
6 Controlling party
The directors control the company.
7 Other information
GKS MURTHY MEDICAL LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
Suite 2, Parkway 5
300 Princess Road
Manchester
England
M14 7HR
GKS MURTHY MEDICAL LIMITED 12366541 false 2024-12-01 2025-11-30 2025-11-30 VT Final Accounts May 2026 Dr Shivalinga Gulyam Kuruba No description of principal activity 12366541 2023-12-01 2024-11-30 12366541 core:WithinOneYear 2024-11-30 12366541 core:ShareCapital 2024-11-30 12366541 core:RetainedEarningsAccumulatedLosses 2024-11-30 12366541 2024-12-01 2025-11-30 12366541 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 12366541 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 12366541 bus:Director40 2024-12-01 2025-11-30 12366541 2 2024-12-01 2025-11-30 12366541 core:PlantMachinery 2024-12-01 2025-11-30 12366541 countries:England 2024-12-01 2025-11-30 12366541 bus:FRS102 2024-12-01 2025-11-30 12366541 bus:FilletedAccounts 2024-12-01 2025-11-30 12366541 2025-11-30 12366541 core:WithinOneYear 2025-11-30 12366541 core:ShareCapital 2025-11-30 12366541 core:RetainedEarningsAccumulatedLosses 2025-11-30 12366541 core:PlantMachinery 2025-11-30 12366541 2024-11-30 12366541 core:PlantMachinery 2024-11-30 iso4217:GBP xbrli:pure